Page last updated: 2024-11-03

probenecid and Leprosy

probenecid has been researched along with Leprosy in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Leprosy: A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bazurov, GI1

Other Studies

1 other study available for probenecid and Leprosy

ArticleYear
[A case of delayed diagnosis of leprosy].
    Vestnik dermatologii i venerologii, 1986, Issue:4

    Topics: Chronic Disease; Diagnostic Errors; Female; Humans; Leprosy; Middle Aged; Neurofibromatosis 1; Probe

1986
chemdatabank.com